Furthermore, our population mimicked the biological/genetic characteristics of MR AML or TP53 AML; thus, due to the number of confounding factors and the rarity of the phenomenon, the low expression of WT1 was not treated in our study as a candidate for a negative prognostic factor. This evidence concerns the gene TP53 and acute myeloid leukemia.